Interview: Raghuveer Kini – Executive Director, Pharmexcil, India

20.04.2018
Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub and gives us his assessment of the recent plateauing of Indian exports as well as an overview of the new trends shaping the international strategies of Indian pharmaceutical companies. Could you briefly introduce Pharmexcil to our international readers?
"Indian pharmaceutical exports have skyrocketed from around USD 3.9 billion in 2004 to reach nearly USD 17 billion today."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
India, Pharmexcil, Pharma, Exports, Association, Strategy

Related Interviews

Luca Visini – Managing Director, Eli Lilly, India

Luca Visini, the recently appointed managing director of Eli Lilly & Company for India, shares with us his first perspective of the Indian ecosystem He also provides insights into some…

Satyanarayana Chava – CEO, Laurus Labs, India

Dr. Satyanarayana Chava, founder and CEO of Laurus Labs, provides insights into the distinctive model that has allowed Laurus to become one of the world’s leading API companies as well…

Bhupendra Sangani – CEO, Galentic, India

Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and non-sterile semi-solid products in the dermatology and ophthalmology arenas, provides insights into the international…

Related Articles

India / Top Five Fastest Growing Local Pharma Companies

The Indian pharma market clocked up double-digit growth of around 15 percent in 2021 (compared to three percent in 2020), driven primarily – but not only – by products related…

Mexico / India Ties Deepen; Lilly COVID Drugs Approved; Lithium Opportunities

The latest from Mexican pharma, including government talks with Indian authorities to provide low-cost medicines, a new distribution pilot program led by the military, the authorization of two Lilly monoclonal…

India / Piramal Demerges Pharma Business; Lundbeck Exits; Bharat Biotech & The World’s First Malaria Vaccine

The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15 pharma billionaires, Danish CNS firm Lundbeck’s decision to…

Latest Report

Turkey Pharma Report 2021

Related Content

India
Pharmexcil
Pharma
Exports
Association
Strategy